David de Graaf Email & Phone Number
Co-Founder, CEO and President @ Reverb Therapeutics
5 free lookup(s). No credit card required.
If you need more lookups,
subscriptions start at $34 USD/month.
David de Graaf Location
- Boston, MA, US
David de Graaf Work
- Co-Founder, CEO and President @ (September 2022 - Present)
- Co-founder and Board Chair @ NewCo (February 2024 - Present)
- Chairperson @ (December 2022 - Present)
- Managing Partner @ Inkling LLC (January 2018 - Present)
- Strategic Advisor @ (June 2022 - June 2023)
- President and CEO @ (September 2020 - June 2022)
- CEO and President @ Comet Therapeutics (exited, VectivBio) (November 2018 - July 2020)
- Entrepreneur in Residence @ (February 2018 - November 2018)
- CEO @ Syntimmune (exited, Alexion, $1.2B) (July 2016 - January 2018)
- Scientific Advisory Board Member @ MIT Center for Cancer Systems Biology (June 2011 - January 2018)
- Venture Partner @ (November 2015 - July 2016)
David de Graaf Education
- Weizmann Institute of Science
(Genomics)
1995-1997 - University of Illinois at Chicago
Doctor of Philosophy (Genetics)
1989-1995 - Utrecht University
Master of Science (Genetics)
1984-1989
David de Graaf Skills
- Systems Biology
- Life Sciences
- Biopharmaceuticals
- Molecular Biology
- Pharmaceuticals
- Biotechnology
- Drug Discovery
- R&D
- Genomics
- Computational Biology
- Genetics
- Research
- Oncology
- Clinical Research
- Bioinformatics
- Immunology
- Translational Research
- Lifesciences
- Pharmaceutical Industry
- Science
- Purification
- Biomarkers
- PCR
- Assay Development
- Pharmacology
- Clinical Development
- Drug Development
- Toxicology
- Biomarker Discovery
- Chemistry
- Cell
- Biochemistry
- Cancer
- Informatics
- Mass Spectrometry
- Technology Transfer
- Proteomics
- Neuroscience
- Clinical Trials
- Cell Biology
- Cell Culture
- Protein Chemistry
- Team Leadership
- Cross-functional Team Leadership
- Strategy
- Research and Development (R&D)
- Executive Management
- Entrepreneurship
- Public Speaking
- Research and Development R&d
- Cross Functional Team Leadership
- Business Strategy
- Startups
- Social Media
- Research and Development
David de Graaf Summary
- David de Graaf, based in Boston, MA, US, is currently a Co-Founder, CEO and President at Reverb Therapeutics. David de Graaf brings experience from previous roles at NewCo, Ability Biologics, Inkling LLC and Abcuro, Inc. David de Graaf holds a 1995 - 1997 Weizmann Institute of Science. With a robust skill set that includes Systems Biology, Life Sciences, Biopharmaceuticals, Molecular Biology, Pharmaceuticals and more. David de Graaf has 4 emails and 3 mobile phone numbers on RocketReach.
Looking for a different David de Graaf?
Find contact details for 700 million professionals.
Others Named David de Graaf
David de Graaf
Director of Information Systems and Technology
Airdrie, AB, CA
David de Graaf
Key Accountmanager Direct Sales
Netherlands
David de Graaf
Project Manager ELDS
Amsterdam, NH, NL
David de Graaf
Accountmanager
Dongen, NB, NL
Top Reverb Therapeutics Employees
Surjit Dixit
Founder and CSO
Vancouver, BC, CA
Neal Gordon
Strategic Advisor to the CEO and board
Brookline, MA, US
John Burke
Chief Pharmacology Officer
Boston, MA, US
Mark Fogg
VP, Immunology
Vancouver, BC, CA
Abhishek Mukhopadhyay
Director
Vancouver, BC, CA
Diana Hausman
Chief Medical Officer
Kirkland, WA, US
Ahmed al-Khateeb
Chief Business Officer
Boston, MA, US
Libin Abraham
Senior Scientist - Immunology
Kirkland, WA, US
G2 Crowd Trusted
300K+ Plugin Users
© 2026 RocketReach.co